Description
PF-07104091 is a selective CDK2 inhibitor.
Product Unit Size | Cost | Quantity | Stock |
---|
PF-07104091 is a selective CDK2 inhibitor.
Cas No. | 2460249-19-6 |
---|---|
Purity | ≥98% |
Formula | C19H28N6O4 |
Formula Wt. | 404.47 |
IUPAC Name | [(1R,3S)-3-[3-[[5-(methoxymethyl)-2-methylpyrazole-3-carbonyl]amino]-1H-pyrazol-5-yl]cyclopentyl] N-propan-2-ylcarbamate |
Synonym | PF-07104091, PF 07104091, PF07104091, PF-7104091, PF 7104091, PF7104091 |
Appearance | White powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Rifamycin derivative, induces pore formation in...
PIKfyve inhibitor.
GABA potentiator, voltage-gated Na+ and ATP-sen...
Pyrrolopyrimidine; Akt inhibitor.
Synthesis impurity
Immunomodulator; teratogen.
Pim kinase inhibitor.
Nicotinic acid derivative; InhA inhibitor.
Zinc chelator
AT1 antagonist.
BH3 mimetic; Bcl-2 inhibitor.
Mast cell destabilizer; potential TRP antagonis...
Cationic lipid polypeptide, mixture of polymyxi...
Peptide, oxytocin-vasopressin analog.
STAT3 inhibitor.
Nucleoside (thymidine) analog; RT inhibitor.
SK K+ channel blocker, EGFR inhibitor.
Alpha blocker and vasoactive agent.
Derivative of methyl caffeate, hydroxycinnamic ...